Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
AstraZeneca
US Army
QuintilesIMS
Cerilliant
Cantor Fitzgerald
US Department of Justice
Merck
Boehringer Ingelheim
Argus Health

Generated: December 12, 2017

DrugPatentWatch Database Preview

Hetero Labs Ltd Iii Company Profile

« Back to Dashboard

What is the competitive landscape for HETERO LABS LTD III, and what generic and branded alternatives to HETERO LABS LTD III drugs are available?

HETERO LABS LTD III has twenty-four approved drugs.

There are four tentative approvals on HETERO LABS LTD III drugs.

Summary for Hetero Labs Ltd Iii

US Patents:0
Tradenames:20
Ingredients:20
NDAs:24
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Hetero Labs Ltd IiiINDOMETHACINindomethacinCAPSULE, EXTENDED RELEASE;ORAL201807-001Sep 28, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd IiiFINASTERIDEfinasterideTABLET;ORAL090060-001Jul 1, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd IiiTORSEMIDEtorsemideTABLET;ORAL079234-001Jan 27, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd IiiLEVETIRACETAMlevetiracetamTABLET;ORAL090515-001Oct 8, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd IiiDULOXETINE HYDROCHLORIDEduloxetine hydrochlorideCAPSULE, DELAYED REL PELLETS;ORAL204343-002Aug 3, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd IiiSIMVASTATINsimvastatinTABLET;ORAL200895-004Nov 25, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd IiiHYDRALAZINE HYDROCHLORIDEhydralazine hydrochlorideTABLET;ORAL040901-004Sep 12, 2008AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd IiiTORSEMIDEtorsemideTABLET;ORAL079234-003Jan 27, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd IiiLITHIUM CARBONATElithium carbonateCAPSULE;ORAL090702-001Sep 25, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd IiiHYDRALAZINE HYDROCHLORIDEhydralazine hydrochlorideTABLET;ORAL040901-003Sep 12, 2008AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Citi
Federal Trade Commission
Fish and Richardson
Dow
UBS
Johnson and Johnson
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot